SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences - Quaterly Results

20 May 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 1621.93 millions, up 22.94% as compared to Rs. 1319.29 millions during the corresponding quarter last year.The Profit  for the quarter ended March 2022 of  Rs. 202.65  millions  grew by 57.45% from Rs. 128.71 millions.Operating profit surged to 315.61 millions from the corresponding previous quarter of 244.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1621.93 1319.29 22.94 7791.56 4876.99 59.76 7791.56 4876.99 59.76
Other Income 0.41 6.56 -93.75 31.04 37.33 -16.85 31.04 37.33 -16.85
PBIDT 315.61 244.03 29.33 1488.20 876.53 69.78 1488.20 876.53 69.78
Interest 10.57 28.72 -63.20 48.47 136.33 -64.45 48.47 136.33 -64.45
PBDT 305.04 215.31 41.67 1439.73 740.20 94.51 1439.73 740.20 94.51
Depreciation 43.27 44.82 -3.46 171.34 163.08 5.06 171.34 163.08 5.06
PBT 261.77 170.49 53.54 1268.39 577.12 119.78 1268.39 577.12 119.78
TAX 59.12 41.78 41.50 309.98 134.80 129.96 309.98 134.80 129.96
Deferred Tax -7.38 18.73 -139.40 -11.52 20.11 -157.28 -11.52 20.11 -157.28
PAT 202.65 128.71 57.45 958.41 442.32 116.68 958.41 442.32 116.68
Equity 96.94 96.94 0.00 96.94 96.94 0.00 96.94 96.94 0.00
PBIDTM(%) 19.46 18.50 5.20 19.10 17.97 6.27 19.10 17.97 6.27

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×